In brief Shifting health priorities are influencing alcohol choices across demographics, occasions and household dynamics
Due to the promotive effect of GLP-1R agonism on -cells proliferation and survival, concerns of tumorigenesis, especially pancreatic cancers, have been raised about incretin-based therapies (89)
Initial clinical assessment: Healthcare providers should obtain a detailed history including symptom onset, character, severity, and relationship to medication initiation or dose changes
Drugs that raise blood glucose (such as corticosteroids, certain antipsychotics, or thiazide diuretics) may counteract glycaemic benefits
Role of tau as a microtubule-associated protein: Structural and functional aspects
Implications and Future Directions The GLP-1 manufacturing ramp-up has profound implications across healthcare and industry: Patient access vs equity: In the short term, supply constraints may limit patient access despite massive investments